BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+3.08%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$3.55B
AUM Growth
+$3.55B
(-1.7%)
Cap. Flow
+$132M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
70.18%
Holding
30
New
3
Increased
10
Reduced
6
Closed
–
Top Buys
| 1 |
Wave Life Sciences
WVE
|
$30M |
| 2 |
Voyager Therapeutics
VYGR
|
$25.6M |
| 3 |
CELG
Celgene Corp
CELG
|
$25M |
| 4 |
AKCA
Akcea Therapeutics, Inc. Common Stock
AKCA
|
$21.7M |
| 5 |
Esperion Therapeutics
ESPR
|
$17.4M |
Top Sells
| 1 |
SAGE
Sage Therapeutics
SAGE
|
$8.24M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$7.62M |
| 3 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$5.94M |
| 4 |
Halozyme
HALO
|
$2.15M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$1.72M |
Sector Composition
| 1 | Healthcare | 92.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ionis Pharmaceuticals
IONS
$6.79B
| $409M | 11.52% | 8,136,334 +274,400 | +3% | +$13.8M |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $357M | 10.06% | 3,424,298 +240,000 | +8% | +$25M |
|
3
Incyte
INCY
$16.5B
| $350M | 9.86% | 3,698,322 +30,000 | +0.8% | +$2.84M |
|
4
Neurocrine Biosciences
NBIX
$13.8B
| $268M | 7.54% | 3,452,753 -10,000 | -0.3% | -$776K |
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $221M | 6.23% | 1,475,445 | – | – |
|
6
Gilead Sciences
GILD
$140B
| $199M | 5.6% | 2,774,596 | – | – |
|
|
RDUS
7
DELISTED
Radius Health, Inc.
RDUS
| $181M | 5.1% | 5,698,799 +200,000 | +4% | +$6.35M |
|
|
8
Halozyme
HALO
$8.56B
| $173M | 4.86% | 8,520,137 -105,914 | -1% | -$2.15M |
|
|
SAGE
9
DELISTED
Sage Therapeutics
SAGE
| $172M | 4.84% | 1,042,439 -50,000 | -5% | -$8.24M |
|
|
ALXN
10
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $162M | 4.56% | 1,354,428 | – | – |
|
|
11
Esperion Therapeutics
ESPR
$448M
| $156M | 4.38% | 2,362,964 +265,000 | +13% | +$17.4M |
|
|
12
Agios Pharmaceuticals
AGIO
$2.19B
| $156M | 4.38% | 2,719,998 -30,000 | -1% | -$1.72M |
|
|
13
Alnylam Pharmaceuticals
ALNY
$58.5B
| $134M | 3.76% | 1,051,338 -60,000 | -5% | -$7.62M |
|
|
JUNO
14
DELISTED
Juno Therapeutics, Inc.
JUNO
| $88M | 2.48% | 1,925,000 -130,000 | -6% | -$5.94M |
|
|
TSRO
15
DELISTED
TESARO, Inc.
TSRO
| $86.7M | 2.44% | 1,046,193 +50,000 | +5% | +$4.14M |
|
16
Regeneron Pharmaceuticals
REGN
$61.5B
| $77.1M | 2.17% | 205,000 | – | – |
|
17
MacroGenics
MGNX
$112M
| $49.4M | 1.39% | 2,600,412 +200,000 | +8% | +$3.8M |
|
|
AVXS
18
DELISTED
AveXis, Inc. Common Stock
AVXS
| $44.6M | 1.26% | 402,800 | – | – |
|
|
MYOV
19
DELISTED
Myovant Sciences Ltd.
MYOV
| $44.3M | 1.25% | 3,507,882 +30,000 | +0.9% | +$379K |
|
|
ITCI
20
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $31.9M | 0.9% | 2,200,000 | – | – |
|
|
21
Wave Life Sciences
WVE
$1.53B
| $30M | 0.85% | +856,096 | New | +$30M |
|
|
ICPT
22
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $28.4M | 0.8% | 485,719 | – | – |
|
|
ALDR
23
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $25.9M | 0.73% | 2,266,008 | – | – |
|
|
24
Voyager Therapeutics
VYGR
$186M
| $25.6M | 0.72% | +1,539,520 | New | +$25.6M |
|
|
AKCA
25
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $21.7M | 0.61% | +1,248,650 | New | +$21.7M |
|